We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRC icon
2026
Gorman-Rupp
GRC
$2.14B
$18.5K ﹤0.01%
388
BHB icon
2027
Bar Harbor Bankshares
BHB
$663M
$18.5K ﹤0.01%
596
DCO icon
2028
Ducommun
DCO
$2.67B
$18.4K ﹤0.01%
193
ICFI icon
2029
ICF International
ICFI
$1.52B
$18.3K ﹤0.01%
215
-594
-73% -$50.4K
IE icon
2030
Ivanhoe Electric
IE
$1.41B
$18.3K ﹤0.01%
1,142
NPKI
2031
NPK International
NPKI
$1.13B
$18.3K ﹤0.01%
1,531
DBRG icon
2032
DigitalBridge
DBRG
$2.93B
$18K ﹤0.01%
1,176
-201
-15% -$2.42K
IOO icon
2033
iShares Global 100 ETF
IOO
$8.69B
$18K ﹤0.01%
+142
New +$17.7K
SOC icon
2034
Sable Offshore Corp
SOC
$843M
$18K ﹤0.01%
+1,991
New +$18.8K
PRFZ icon
2035
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.76B
$17.9K ﹤0.01%
390
BIPC icon
2036
Brookfield Infrastructure
BIPC
$5.14B
$17.9K ﹤0.01%
394
TFIN icon
2037
Triumph Financial Inc
TFIN
$1.8B
$17.9K ﹤0.01%
285
-216
-43% -$12.1K
BROS icon
2038
Dutch Bros
BROS
$8.97B
$17.8K ﹤0.01%
291
PHAT icon
2039
Phathom Pharmaceuticals
PHAT
$958M
$17.8K ﹤0.01%
1,073
BCO icon
2040
Brink's
BCO
$4.83B
$17.7K ﹤0.01%
152
-6
-4% -$686
LINE
2041
Lineage Inc
LINE
$9.84B
$17.7K ﹤0.01%
505
+426
+539% +$15.7K
GEO icon
2042
The GEO Group
GEO
$4.12B
$17.7K ﹤0.01%
1,095
-568
-34% -$9.47K
ASIX icon
2043
AdvanSix
ASIX
$562M
$17.6K ﹤0.01%
1,016
+145
+17% +$2.53K
LYTS icon
2044
LSI Industries
LYTS
$853M
$17.6K ﹤0.01%
958
NEO icon
2045
NeoGenomics
NEO
$1.71B
$17.5K ﹤0.01%
1,492
-16
-1% -$173
CHWY icon
2046
Chewy
CHWY
$9.33B
$17.5K ﹤0.01%
530
-14,363
-96% -$499K
WHR icon
2047
Whirlpool
WHR
$2.56B
$17.5K ﹤0.01%
242
-6,959
-97% -$514K
BE icon
2048
Bloom Energy
BE
$46.7B
$17.4K ﹤0.01%
200
+183
+1,076% +$19.2K
FMNB icon
2049
Farmers National Banc Corp
FMNB
$936M
$17.3K ﹤0.01%
1,296
-135
-9% -$1.85K
ALGM icon
2050
Allegro MicroSystems
ALGM
$8.02B
$17.2K ﹤0.01%
653
-126
-16% -$3.47K

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.